Literature DB >> 24718111

Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.

F Momen-Heravi1, A J Trachtenberg2, W P Kuo3, Y S Cheng4.   

Abstract

MicroRNAs (miRNAs) in human saliva have recently demonstrated to be potential biomarkers for diagnosis purposes. However, lack of well-characterized/matched clinical groups and lack of suitable endogenous control (EC) for salivary extracellular miRNA detection and normalization are among the restrictions of applying salivary-based miRNA biomarker discovery. In the present study, we examined the differential expression pattern of miRNAs among 4 groups of subjects-including patients with oral squamous cell carcinoma (OSCC), patients with OSCC in remission (OSCC-R), patients with oral lichen planus, and healthy controls (HCs)-using a genomewide high-throughput miRNA microarray. First, we systematically screened 10 pooling samples and 34 individual samples of different groups to find a proper EC miRNA. We then investigated the genomewide expression patterns of differentially expressed miRNAs in saliva of different groups using NanoString nCounter miRNA expression assay and real-time quantitative polymerase chain reaction, followed by construction of receiver operating characteristic curves to determine the sensitivity and specificity of the assay. We identified miRNA-191 as a suitable EC miRNA with minimal intergroup and intragroup variability, and we used it for normalization. Of more than 700 miRNAs tested, 13 were identified as being significantly deregulated in saliva of OSCC patients compared to HCs: 11 miRNAs were underexpressed (miRNA-136, miRNA-147, miRNA-1250, miRNA-148a, miRNA-632, miRNA-646, miRNA668, miRNA-877, miRNA-503, miRNA-220a, miRNA-323-5p), and 2 miRNAs were overexpressed (miRNA-24, miRNA-27b). MiRNA-136 was underexpressed in both OSCC vs. HCs and OSCC vs. OSCC-R. MiRNA-27b levels were significantly higher in OSCC patients compared to those found in HCs, patients with OSCC-R, and patients with oral lichen planus and served as a characteristic biomarker of OSCC. Receiver operating characteristic curve analyses showed that miRNA-27b could be a valuable biomarker for distinguishing OSCC patients from the other groups. Our novel findings established a reliable EC miRNA for salivary-based diagnostic and indicate that the salivary miRNA profiles are discriminatory in OSCC patients. © International & American Associations for Dental Research.

Entities:  

Keywords:  biomarker; human; microRNA-191; microRNA-27a; saliva; squamous cell carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24718111      PMCID: PMC4107544          DOI: 10.1177/0022034514531018

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  28 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids.

Authors:  Zhanzhi Hu; Bernhard G Zimmermann; Hui Zhou; Jianghua Wang; Bradley S Henson; Weixia Yu; David Elashoff; Guido Krupp; David T Wong
Journal:  Clin Chem       Date:  2008-03-20       Impact factor: 8.327

3.  Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.

Authors:  J B Kjersem; T Ikdahl; O C Lingjaerde; T Guren; K M Tveit; E H Kure
Journal:  Mol Oncol       Date:  2013-09-21       Impact factor: 6.603

4.  Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population.

Authors:  Ole Brinkmann; Dragana A Kastratovic; Milovan V Dimitrijevic; Vitomir S Konstantinovic; Drago B Jelovac; Jadranka Antic; Vladimir S Nesic; Srdjan Z Markovic; Zeljko R Martinovic; David Akin; Nadine Spielmann; Hui Zhou; David T Wong
Journal:  Oral Oncol       Date:  2010-11-24       Impact factor: 5.337

5.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Authors:  Mattia Boeri; Carla Verri; Davide Conte; Luca Roz; Piergiorgio Modena; Federica Facchinetti; Elisa Calabrò; Carlo M Croce; Ugo Pastorino; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

8.  microRNA expression profiles in oral squamous cell carcinoma.

Authors:  Daisuke Soga; Sayaka Yoshiba; Sunao Shiogama; Hiroaki Miyazaki; Seiji Kondo; Satoru Shintani
Journal:  Oncol Rep       Date:  2013-05-23       Impact factor: 3.906

9.  Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer.

Authors:  Lianjin Jin; Oliver Wessely; Eric G Marcusson; Cristina Ivan; George A Calin; Suresh K Alahari
Journal:  Cancer Res       Date:  2013-01-21       Impact factor: 12.701

10.  MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.

Authors:  Young Tae Park; Ju-Yeon Jeong; Mi-Jung Lee; Kwang-Il Kim; Tae-Heon Kim; Young-do Kwon; Chan Lee; Ok Jun Kim; Hee-Jung An
Journal:  J Ovarian Res       Date:  2013-03-22       Impact factor: 4.234

View more
  55 in total

Review 1.  Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids.

Authors:  Mohammad Amin Javidi; Amir Hossein Ahmadi; Babak Bakhshinejad; Nazila Nouraee; Sadegh Babashah; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-11-02       Impact factor: 3.064

Review 2.  The usefulness of microRNA in urine and saliva as a biomarker of gastroenterological cancer.

Authors:  Isamu Hoshino
Journal:  Int J Clin Oncol       Date:  2021-04-09       Impact factor: 3.402

Review 3.  Epigenetics of oral and oropharyngeal cancers.

Authors:  Daniela Russo; Francesco Merolla; Silvia Varricchio; Giovanni Salzano; Giovanni Zarrilli; Massimo Mascolo; Viviana Strazzullo; Rosa Maria Di Crescenzo; Angela Celetti; Gennaro Ilardi
Journal:  Biomed Rep       Date:  2018-07-27

4.  Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis.

Authors:  K Hema Shree; Pratibha Ramani; Herald Sherlin; Gheena Sukumaran; Gifrrina Jeyaraj; K R Don; Archana Santhanam; Abilasha Ramasubramanian; R Sundar
Journal:  Pathol Oncol Res       Date:  2019-02-02       Impact factor: 3.201

5.  The Breadth of Oral Health Research: Translating to Clinical Practice.

Authors:  N P T Innes; W V Giannobile
Journal:  J Dent Res       Date:  2014-07       Impact factor: 6.116

Review 6.  The utilization of saliva as an early diagnostic tool for oral cancer: microRNA as a biomarker.

Authors:  J S Ghizoni; R Nichele; M T de Oliveira; S Pamato; J R Pereira
Journal:  Clin Transl Oncol       Date:  2019-09-27       Impact factor: 3.405

Review 7.  Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.

Authors:  Guy R Adami; Jessica L Tang; Michael R Markiewicz
Journal:  Oral Oncol       Date:  2017-04-17       Impact factor: 5.337

Review 8.  Salivary extracellular noncoding RNA: emerging biomarkers for molecular diagnostics.

Authors:  David T W Wong
Journal:  Clin Ther       Date:  2015-03-18       Impact factor: 3.393

9.  MiRNA-323-5p Promotes U373 Cell Apoptosis by Reducing IGF-1R.

Authors:  Hong-An Yang; Xiang Wang; Feng Ding; Qi Pang
Journal:  Med Sci Monit       Date:  2015-12-13

Review 10.  Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.